The final major drugmaker President Donald Trump had pressed to accept a most-favored-nation deal has signed an agreement ...
President Donald Trump slept for a maximum of four hours and 48 minutes last night, his frantic Truth Social tirades have ...
US President Donald Trump appeared with his eyes closed during a White House healthcare affordability event on Thursday. The ...
Major U.S. health insurers will standardize prior authorization requirements in 2026, while the Trump administration struck a drug pricing deal with Regeneron to cut costs. A Medicare pilot for weight ...
The developer-in-chief launched into a 10-minute rant about renovating the century-old water feature after posting a Truth ...
Donald Trump is under renewed scrutiny after a former CIA analyst warned of his dangerous fascination with nuclear weapons, ...
The Justice Department on Friday announced it's pausing its investigation of Federal Reserve Chairman Jerome Powell.
Lilly shares dipped, and Novo’s climbed, as Foundayo’s early trajectory diverged from that of oral Wegovy. Elsewhere, Regeneron inked a drug price deal and two companies announced leadership changes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results